Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation.

[1]  F. Bolás-Fernández,et al.  Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale. , 2020, International journal of pharmaceutics.

[2]  P. K. Sharma.  Atherosclerosis. , 2020, The Journal of the Association of Physicians of India.

[3]  Reena Gupta,et al.  The Why, Where, Who, How, and What of the vesicular delivery systems. , 2019, Advances in colloid and interface science.

[4]  I. Sharifi,et al.  Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[5]  S. De Santis,et al.  Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[6]  Vrinda Gote,et al.  Ocular Drug Delivery: Present Innovations and Future Challenges , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[7]  Jingling Tang,et al.  α-Tocopherol liposome loaded chitosan hydrogel to suppress oxidative stress injury in cardiomyocytes. , 2019, International journal of biological macromolecules.

[8]  Y. Kuo,et al.  Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration. , 2019, Acta biomaterialia.

[9]  B. Ortel,et al.  Biologics for the primary care physician: Review and treatment of psoriasis. , 2019, Disease-a-month : DM.

[10]  M. Amaral,et al.  Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[11]  S. Amel Jamehdar,et al.  Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV , 2019, Artificial cells, nanomedicine, and biotechnology.

[12]  Xiaowei Xu,et al.  Apoptotic cell-mimicking gold nanocages loaded with LXR agonist for attenuating the progression of murine systemic lupus erythematosus. , 2019, Biomaterials.

[13]  Gaurav Chauhan,et al.  IGF-II-Conjugated Nanocarrier for Brain-Targeted Delivery of p11 Gene for Depression , 2019, AAPS PharmSciTech.

[14]  Shih-Jen Chen,et al.  Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization , 2019, International journal of molecular sciences.

[15]  Bin Chen,et al.  Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis , 2019, International journal of nanomedicine.

[16]  Jianzhong Han,et al.  Advances and challenges in liposome digestion: Surface interaction, biological fate, and GIT modeling. , 2019, Advances in colloid and interface science.

[17]  W. Jiskoot,et al.  Anionic 1,2‐distearoyl‐sn‐glycero‐3‐phosphoglycerol (DSPG) liposomes induce antigen‐specific regulatory T cells and prevent atherosclerosis in mice , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Xiangrong Song,et al.  TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma , 2018, International journal of pharmaceutics.

[19]  A. Rathore,et al.  Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies , 2018, Drug development and industrial pharmacy.

[20]  H. Moghimi,et al.  Advanced Therapy in Cancer: Stimuli-Responsive Nanocarriers for On-Demand Drug Delivery , 2018, Topics in Anti-Cancer Research: Volume 7.

[21]  Guang Yang,et al.  Cancer hallmarks and malignancy features: Gateway for improved targeted drug delivery. , 2018, Biotechnology advances.

[22]  J. Sousa,et al.  Targeted Theranostic Nanoparticles for Brain Tumor Treatment , 2018, Pharmaceutics.

[23]  C. Dass,et al.  Recent advancements in oral administration of insulin‐loaded liposomal drug delivery systems for diabetes mellitus , 2018, International journal of pharmaceutics.

[24]  W. Foulsham,et al.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management , 2018, Journal of Ophthalmic Inflammation and Infection.

[25]  J. Morales,et al.  Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches , 2018, Theranostics.

[26]  A. Bannalikar,et al.  Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies , 2018, Drug development and industrial pharmacy.

[27]  A. Khademhosseini,et al.  Overview of Silk Fibroin Use in Wound Dressings. , 2018, Trends in biotechnology.

[28]  H. Fahmy,et al.  Treatment merits of Latanoprost/Thymoquinone – Encapsulated liposome for glaucomatus rabbits , 2018, International journal of pharmaceutics.

[29]  J. Sun,et al.  An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome-protamine-DNA-siRNA complex with cell permeable peptides , 2018, International journal of molecular medicine.

[30]  Yueji Sun,et al.  Mindful exercise versus non-mindful exercise for schizophrenia: A systematic review and meta-analysis of randomized controlled trials. , 2018, Complementary therapies in clinical practice.

[31]  P. Wilkinson,et al.  Recent developments in the treatment of major depressive disorder in children and adolescents , 2018, Evidence Based Journals.

[32]  A. Haeri,et al.  Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol , 2018, AAPS PharmSciTech.

[33]  Yash Paul.  Various epileptic seizure detection techniques using biomedical signals: a review , 2018, Brain Informatics.

[34]  M. Shukr,et al.  Amisulpride–CD-Loaded Liposomes: Optimization and In Vivo Evaluation , 2018, AAPS PharmSciTech.

[35]  G. Storm,et al.  Towards clinical translation of ligand‐functionalized liposomes in targeted cancer therapy: Challenges and opportunities , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[36]  C. Nunes,et al.  Hyaluronic acid-conjugated pH-sensitive liposomes for targeted delivery of prednisolone on rheumatoid arthritis therapy. , 2018, Nanomedicine.

[37]  G. Storm,et al.  Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis , 2018, Scientific Reports.

[38]  N. Bavarsad,et al.  Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients , 2018, Drug development and industrial pharmacy.

[39]  A. Lavasanifar,et al.  Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research , 2018, Expert opinion on drug delivery.

[40]  Yimin Zhu,et al.  Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis. , 2018, Acta biomaterialia.

[41]  T. Andresen,et al.  Endothelial Protein C-Targeting Liposomes Show Enhanced Uptake and Improved Therapeutic Efficacy in Human Retinal Endothelial Cells. , 2018, Investigative ophthalmology & visual science.

[42]  Nadeem Ullah,et al.  Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection , 2018, Front. Immunol..

[43]  R. Herrero-Vanrell,et al.  Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment. , 2018, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[44]  R. M. Keegan,et al.  Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[45]  Crispin R Dass,et al.  Oral insulin delivery: existing barriers and current counter‐strategies , 2018, The Journal of pharmacy and pharmacology.

[46]  A. Elaissari,et al.  Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. , 2018, International journal of pharmaceutics.

[47]  S. Majumdar,et al.  Recent advances in topical nano drug-delivery systems for the anterior ocular segment. , 2018, Therapeutic delivery.

[48]  S. Androudi,et al.  A Focus on the Epidemiology of Uveitis , 2018, Ocular immunology and inflammation.

[49]  Jia-You Fang,et al.  Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis , 2018, Nanomaterials.

[50]  Youxin Li,et al.  Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization , 2018, Drug delivery.

[51]  M. L. González-Rodríguez,et al.  Ophthalmic administration of a 10‐fold‐lower dose of conventional nanoliposome formulations caused levels of intraocular pressure similar to those induced by marketed eye drops , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[52]  K. Houkin,et al.  Superior Microvascular Perfusion of Infused Liposome-Encapsulated Hemoglobin Prior to Reductions in Infarctions after Transient Focal Cerebral Ischemia. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[53]  A. Haeri,et al.  State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy , 2017, Iranian journal of pharmaceutical research : IJPR.

[54]  N. Greig,et al.  Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective. , 2017, Current Alzheimer research.

[55]  J. M. de la Fuente,et al.  Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment. , 2017, Current medicinal chemistry.

[56]  J. Qian,et al.  Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes , 2017, British Journal of Ophthalmology.

[57]  S. Salomone,et al.  Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases , 2017, International journal of molecular sciences.

[58]  A. Denniston,et al.  Uveitis: a sight-threatening disease which can impact all systems , 2017, Postgraduate Medical Journal.

[59]  Wahid Khan,et al.  Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo. , 2017, Journal of photochemistry and photobiology. B, Biology.

[60]  Sanaa A. Yassin,et al.  Recent developments in age-related macular degeneration: a review , 2017 .

[61]  G. Stone,et al.  Coronary balloon angioplasty, stents, and scaffolds , 2017, The Lancet.

[62]  E. Kılıç,et al.  Anticonvulsant activity of resveratrol-loaded liposomes in vivo , 2017, Neuroscience.

[63]  F. Burzotta,et al.  Coronary stents and vascular response to implantation: literature review , 2017, Pragmatic and observational research.

[64]  Theodore V. Tselios,et al.  Multiple Sclerosis: Immunopathology and Treatment Update , 2017, Brain sciences.

[65]  R. B. Walker,et al.  Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes. , 2017, International journal of pharmaceutics.

[66]  A. Majid,et al.  Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. , 2017, International journal of pharmaceutics.

[67]  Xuesi Chen,et al.  Nanotherapeutics relieve rheumatoid arthritis , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[68]  Mayyas Al-Remawi,et al.  Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system , 2017, Pharmaceutical development and technology.

[69]  Li Yang,et al.  Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection , 2017, Pharmaceutical development and technology.

[70]  M. Salmona,et al.  Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof‐of‐concept , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[71]  S. Nasoohi,et al.  Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat , 2017, Fundamental & clinical pharmacology.

[72]  Z. Dai,et al.  Liposomal Nanotechnology for Cancer Theranostics. , 2017, Current medicinal chemistry.

[73]  Y. Kuo,et al.  Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment , 2017, International journal of nanomedicine.

[74]  Ruyi Gui,et al.  A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride , 2017, International journal of nanomedicine.

[75]  A. Haeri,et al.  Potential of Liposomes for Enhancement of Oral Drug Absorption. , 2017, Current drug delivery.

[76]  Shahram Rabbani,et al.  Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes. , 2017, Carbohydrate polymers.

[77]  R. Lockey,et al.  Acute asthma, prognosis, and treatment , 2017, The Journal of allergy and clinical immunology.

[78]  Rania M. Hathout,et al.  Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug , 2017, Drug delivery.

[79]  C. Cho,et al.  Drug- and Gene-eluting Stents for Preventing Coronary Restenosis , 2017, Chonnam medical journal.

[80]  Y. Kuo,et al.  Rescuing cholinergic neurons from apoptotic degeneration by targeting of serotonin modulator-and apolipoprotein E-conjugated liposomes to the hippocampus , 2016, International journal of nanomedicine.

[81]  Maryam Dadashi,et al.  Cystic fibrosis lung environment and Pseudomonas aeruginosa infection , 2016, BMC Pulmonary Medicine.

[82]  P. Sharma,et al.  Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents. , 2016, Recent patents on drug delivery & formulation.

[83]  Xing-jie Liang,et al.  Nanotechnology-based strategies for treatment of ocular disease , 2016, Acta pharmaceutica Sinica. B.

[84]  R. Narayan,et al.  Development of risperidone liposomes for brain targeting through intranasal route. , 2016, Life sciences.

[85]  A. Akbarzadeh,et al.  An Update on Biomedical Application of Nanotechnology for Alzheimer’s Disease Diagnosis and Therapy , 2016, Drug Research.

[86]  N. Akhtar,et al.  Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'. , 2016, Progress in lipid research.

[87]  G. Koning,et al.  EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery. , 2016, Colloids and surfaces. B, Biointerfaces.

[88]  N. Santos-Magalhães,et al.  Antidepressant-like activity of liposomal formulation containing nimodipine treatment in the tail suspension test, forced swim test and MAOB activity in mice , 2016, Brain Research.

[89]  S. Govoni,et al.  Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. , 2016, Pharmacological research.

[90]  C. Dass,et al.  Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities , 2016, The Journal of pharmacy and pharmacology.

[91]  P. Upadhyay,et al.  Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route , 2016, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[92]  M. Mohammadnia-Afrouzi,et al.  Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis , 2016, Journal of immunotoxicology.

[93]  Q. Ping,et al.  Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats , 2016, Biological Research.

[94]  S. Mutalik,et al.  Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations , 2016, Journal of liposome research.

[95]  R. Kumar,et al.  Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial. , 2016, JAMA dermatology.

[96]  N. Oku,et al.  Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil. , 2016, International journal of pharmaceutics.

[97]  Meimei Xiong,et al.  Self-enhanced targeted delivery of a cell wall– and membrane-active antibiotics, daptomycin, against staphylococcal pneumonia , 2016, Acta pharmaceutica Sinica. B.

[98]  M. Saif,et al.  The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy , 2016, Expert review of anticancer therapy.

[99]  A. Banga,et al.  Intradermal and follicular delivery of adapalene liposomes , 2016, Drug development and industrial pharmacy.

[100]  B. Boyd,et al.  Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration , 2016, Drug Delivery and Translational Research.

[101]  A. Badawi,et al.  Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients , 2016, Drug delivery.

[102]  M. J. Pérez de Lara,et al.  Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[103]  Y. Barenholz,et al.  A liposomal steroid nano-drug for treating systemic lupus erythematosus , 2016, Lupus.

[104]  Yadong Wang,et al.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. , 2016, Biomaterials.

[105]  H. Wong,et al.  Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[106]  Y. Kashyap,et al.  Recent Advances in Topical Ocular Drug Delivery. , 2016 .

[107]  F. Marques,et al.  Nano- and micro-based systems for immunotolerance induction in multiple sclerosis , 2016, Human vaccines & immunotherapeutics.

[108]  Man Huang,et al.  Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[109]  D. Brooks,et al.  Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease. , 2016, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[110]  Tarun Garg,et al.  Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne , 2016, Artificial cells, nanomedicine, and biotechnology.

[111]  C. Montemagno,et al.  Nanotechnology Applications for Glaucoma , 2016, Asia-Pacific journal of ophthalmology.

[112]  K. Taylor,et al.  Proliposome powders prepared using a slurry method for the generation of beclometasone dipropionate liposomes. , 2015, International journal of pharmaceutics.

[113]  Lindsey T. Brinton,et al.  Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[114]  N. Oku,et al.  Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[115]  Ashish Ranjan Sharma,et al.  Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes , 2015, Journal of Nanobiotechnology.

[116]  N. Fogel.  Tuberculosis: a disease without boundaries. , 2015, Tuberculosis.

[117]  J. Mims.  Asthma: definitions and pathophysiology , 2015, International forum of allergy & rhinology.

[118]  M. de la Fuente,et al.  Nanotherapies for the treatment of ocular diseases. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[119]  R. Koynova,et al.  Recent Progress in Liposome Production, Relevance to Drug Delivery and Nanomedicine. , 2015, Recent patents on nanotechnology.

[120]  Yue Zhao,et al.  Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system , 2015, Scientific Reports.

[121]  Uri Raviv,et al.  Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases , 2015, PloS one.

[122]  Jianping Liu,et al.  Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation , 2015, Drug delivery.

[123]  Chong Li,et al.  Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection , 2015, Drug delivery.

[124]  V. K. Devi,et al.  A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis , 2015, Lung India : official organ of Indian Chest Society.

[125]  Diederik F Van Wijk,et al.  Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[126]  Yong Xu,et al.  Pirfenidone-loaded liposomes for lung targeting: preparation and in vitro/in vivo evaluation , 2015, Drug design, development and therapy.

[127]  Xin-guo Jiang,et al.  Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease , 2015, Pharmaceutical Research.

[128]  P. Fanti,et al.  Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery , 2015, Drug design, development and therapy.

[129]  M. Puig-Domingo,et al.  Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes , 2015, PloS one.

[130]  P. Tipping,et al.  Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes. , 2015, Cardiovascular research.

[131]  Louise van der Weerd,et al.  Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[132]  Abdelwahab Omri,et al.  Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients. , 2015, The Journal of antimicrobial chemotherapy.

[133]  Mansoor M Amiji,et al.  Targeted delivery systems for biological therapies of inflammatory diseases , 2015, Expert opinion on drug delivery.

[134]  A. Molinari,et al.  Liposomes as nanomedical devices , 2015, International journal of nanomedicine.

[135]  H. Tada,et al.  Efficient delivery to human lung fibroblasts (WI-38) of pirfenidone incorporated into liposomes modified with truncated basic fibroblast growth factor and its inhibitory effect on collagen synthesis in idiopathic pulmonary fibrosis. , 2015, Biological & pharmaceutical bulletin.

[136]  Yi-xiao Luo,et al.  Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[137]  J. Surdam,et al.  The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. , 2015, The Journal of arthroplasty.

[138]  G. Baldi,et al.  Nanomaterial Applications in Multiple Sclerosis Inflamed Brain , 2015, Journal of Neuroimmune Pharmacology.

[139]  R. M. Freitas,et al.  Acute toxicity and anticonvulsant activity of liposomes containing nimodipine on pilocarpine-induced seizures in mice , 2015, Neuroscience Letters.

[140]  Madhu Gupta,et al.  Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy , 2014, Artificial cells, nanomedicine, and biotechnology.

[141]  I. Kaur,et al.  Nanotherapy for posterior eye diseases. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[142]  J. M. Marchetti,et al.  Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. , 2014, Colloids and surfaces. B, Biointerfaces.

[143]  R. Herrero-Vanrell,et al.  Hybrid Formulations of Liposomes and Bioadhesive Polymers Improve the Hypotensive Effect of the Melatonin Analogue 5-MCA-NAT in Rabbit Eyes , 2014, PloS one.

[144]  J. Desbrières,et al.  Modulated release from liposomes entrapped in chitosan/gelatin hydrogels. , 2014, Materials science & engineering. C, Materials for biological applications.

[145]  G. Storm,et al.  Liposomal corticosteroids for the treatment of inflammatory disorders and cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[146]  R. Linker,et al.  Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis , 2014, Journal of Neuroimmunology.

[147]  A. Fadda,et al.  Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin. , 2014, International journal of pharmaceutics.

[148]  Jin-Chul Kim,et al.  In vitro skin permeation and anti-atopic efficacy of lipid nanocarriers containing water soluble extracts of Houttuynia cordata , 2014, Drug development and industrial pharmacy.

[149]  Su-Eon Jin,et al.  Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion , 2014, International journal of nanomedicine.

[150]  Shinichi Kaneda,et al.  Efficacy of liposome-encapsulated hemoglobin in a rat model of cerebral ischemia. , 2014, Artificial organs.

[151]  Jie Shi,et al.  cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[152]  Shutao Guo,et al.  Nanoparticles containing insoluble drug for cancer therapy. , 2014, Biotechnology advances.

[153]  J. Clancy,et al.  Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients , 2014, Expert opinion on investigational drugs.

[154]  Tianfu Wang,et al.  The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. , 2014, Biomaterials.

[155]  P. Gaillard,et al.  Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation. , 2014, Investigative ophthalmology & visual science.

[156]  S. Moss,et al.  Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes. , 2014, Small.

[157]  R. Latkany,et al.  Diagnosis of dry eye disease and emerging technologies , 2014, Clinical ophthalmology.

[158]  K. Houkin,et al.  Post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injury , 2014, Brain Research.

[159]  J. Irache,et al.  Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis , 2014, Expert opinion on drug delivery.

[160]  Reena Gupta,et al.  Application of Liposomes in Treatment of Rheumatoid Arthritis: Quo Vadis , 2014, TheScientificWorldJournal.

[161]  V. Pokharkar,et al.  Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation. , 2014, International journal of pharmaceutics.

[162]  Yongtai Zhang,et al.  Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis , 2014, International journal of nanomedicine.

[163]  B. Leonard.  Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[164]  Qiang Zhang,et al.  Combination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenib. , 2013, Investigative ophthalmology & visual science.

[165]  V. Tam,et al.  Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model. , 2013, International journal of antimicrobial agents.

[166]  W. Khalil,et al.  Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment. , 2013, Journal of biomedical nanotechnology.

[167]  D. D. de Araújo,et al.  Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches , 2013, Expert opinion on drug delivery.

[168]  Vanessa Migliaccio,et al.  Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell. , 2013, Experimental parasitology.

[169]  Wen-jie Ji,et al.  Modulation of Mononuclear Phagocyte Inflammatory Response by Liposome-Encapsulated Voltage Gated Sodium Channel Inhibitor Ameliorates Myocardial Ischemia/Reperfusion Injury in Rats , 2013, PloS one.

[170]  Neeraj Kumar,et al.  Development of Novel Elastic Vesicle-Based Topical Formulation of Cetirizine Dihydrochloride for Treatment of Atopic Dermatitis , 2013, AAPS PharmSciTech.

[171]  M. Mohebali,et al.  Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis , 2013, Journal of liposome research.

[172]  T. Aoyama,et al.  Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. , 2013, American journal of physiology. Heart and circulatory physiology.

[173]  S. R. Chennamaneni,et al.  Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[174]  Seemalata Jain,et al.  Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice , 2013, Fundamental & clinical pharmacology.

[175]  Abdelwahab Omri,et al.  Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors , 2013, Antimicrobial Agents and Chemotherapy.

[176]  T. Fahmy,et al.  Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. , 2013, The Journal of clinical investigation.

[177]  S. Krol,et al.  Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. , 2013, Chemical reviews.

[178]  I. Sancho-Martinez,et al.  Reprogramming toward heart regeneration: stem cells and beyond. , 2013, Cell stem cell.

[179]  E. Bendas,et al.  Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. , 2013, International journal of pharmaceutics.

[180]  L. Kumar,et al.  Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis , 2013, Artificial cells, nanomedicine, and biotechnology.

[181]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[182]  M. Dubina,et al.  Liposome-encapsulated peptides protect against experimental allergic encephalitis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[183]  N. Oku,et al.  A single injection of liposomal asialo-erythropoietin improves motor function deficit caused by cerebral ischemia/reperfusion. , 2012, International journal of pharmaceutics.

[184]  J. Silverman,et al.  Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine , 2012, Cancer Chemotherapy and Pharmacology.

[185]  C. Stremnitzer,et al.  Interleukin-10: An Anti-Inflammatory Marker To Target Atherosclerotic Lesions via PEGylated Liposomes , 2012, Molecular pharmaceutics.

[186]  Abdelwahab Omri,et al.  Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection , 2012, Antimicrobial Agents and Chemotherapy.

[187]  W. Pardridge,et al.  Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[188]  Y. Li,et al.  EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats. , 2012, Investigative ophthalmology & visual science.

[189]  G. Barratt,et al.  Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity. , 2012, International journal of pharmaceutics.

[190]  N. Škalko-Basnet,et al.  Improved burns therapy: liposomes-in-hydrogel delivery system for mupirocin. , 2012, Journal of pharmaceutical sciences.

[191]  Yoshihiko Araki,et al.  Liposomes and nanotechnology in drug development: focus on ocular targets , 2012, International journal of nanomedicine.

[192]  K. Nicolay,et al.  Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[193]  Ming Yang,et al.  Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats , 2012, International journal of nanomedicine.

[194]  M. Bebawy,et al.  Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia , 2012, Pharmaceutical Research.

[195]  Yi-xiao Luo,et al.  PI3K/Akt Signaling Pathway in the Basolateral Amygdala Mediates the Rapid Antidepressant-like Effects of Trefoil Factor 3 , 2012, Neuropsychopharmacology.

[196]  G. Golomb,et al.  Liposomal alendronate for the treatment of restenosis. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[197]  A. Sigal,et al.  Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[198]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[199]  E. M. Lima,et al.  Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains , 2012, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[200]  Pathomthat Srisuk,et al.  Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. , 2012, International journal of pharmaceutics.

[201]  R. Boellaard,et al.  P-Glycoprotein Function at the Blood–Brain Barrier: Effects of Age and Gender , 2012, Molecular Imaging and Biology.

[202]  T. Yen,et al.  Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging , 2012, International journal of nanomedicine.

[203]  H. Hamishehkar,et al.  Liposomes in cosmeceutics , 2012, Expert opinion on drug delivery.

[204]  L. DeLouise,et al.  Applications of nanotechnology in dermatology. , 2012, The Journal of investigative dermatology.

[205]  Zhijun Yang,et al.  Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery , 2012, International Journal of Nanomedicine.

[206]  N. Miyasaka,et al.  Arthritic Joint-Targeting Small Interfering RNA-Encapsulated Liposome: Implication for Treatment Strategy for Rheumatoid Arthritis , 2012, Journal of Pharmacology and Experimental Therapeutics.

[207]  S. Sadeghian,et al.  PEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosis , 2012, Journal of microencapsulation.

[208]  Qiang Zhang,et al.  Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against the Parkinson’s disease in the MPTP-induced mice model , 2012, Journal of drug targeting.

[209]  Guihua Huang,et al.  Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution , 2011, Drug delivery.

[210]  M. Ono,et al.  Cutaneous leishmaniasis in a Japanese returnee from West Africa successfully treated with liposomal amphotericin B , 2011, The Journal of dermatology.

[211]  S. Joo,et al.  Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in NC/Nga mice , 2011, International journal of nanomedicine.

[212]  Andrew D. Miller,et al.  Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[213]  Tal Dvir,et al.  Nanoparticles targeting the infarcted heart. , 2011, Nano letters.

[214]  H. Takeuchi,et al.  Edaravone-loaded liposome eyedrops protect against light-induced retinal damage in mice. , 2011, Investigative ophthalmology & visual science.

[215]  M. Zilberman,et al.  Novel biodegradable composite wound dressings with controlled release of antibiotics: results in a guinea pig burn model. , 2011, Burns : journal of the International Society for Burn Injuries.

[216]  M. Deveci,et al.  Evaluation of chitosan gel containing liposome‐loaded epidermal growth factor on burn wound healing , 2011, International wound journal.

[217]  S. Sadeghian,et al.  Use of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosis. , 2011, International journal of pharmaceutics.

[218]  G. Betageri,et al.  PEGylated Liposome Encapsulation Increases the Lung Tissue Concentration of Vancomycin , 2011, Antimicrobial Agents and Chemotherapy.

[219]  Dawn Kleindorfer,et al.  Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years , 2011, Stroke.

[220]  J. Beijnen,et al.  Liposomal drug formulations in the treatment of rheumatoid arthritis. , 2011, Molecular pharmaceutics.

[221]  N. McElvaney,et al.  The Effect of Liposome Encapsulation on the Pharmacokinetics of Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) Therapy after Local Delivery to a Guinea Pig Asthma Model , 2011, Pharmaceutical Research.

[222]  Qiang Zhang,et al.  A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model. , 2011, Investigative ophthalmology & visual science.

[223]  H. Cheon,et al.  Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy. , 2011, Die Pharmazie.

[224]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[225]  J. Gubernator,et al.  Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity , 2011, Expert opinion on drug delivery.

[226]  S. Shek,et al.  Liposome‐Encapsulated 0.5% 5‐Aminolevulinic Acid with Intense Pulsed Light for the Treatment of Inflammatory Facial Acne: A Pilot Study , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[227]  N. Oku,et al.  Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416. , 2011, Archives of ophthalmology.

[228]  S. Chang,et al.  0.5% Liposome-encapsulated 5-aminolevulinic acid (ALA) photodynamic therapy for acne treatment , 2011, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[229]  W. Shao,et al.  Tissue distribution and pulmonary targeting studies of cefpiramide sodium-loaded liposomes , 2011, Journal of drug targeting.

[230]  P. Bjerring,et al.  Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation , 2011, Journal of the European Academy of Dermatology and Venereology.

[231]  Y. Choi,et al.  Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. , 2010, International journal of pharmaceutics.

[232]  Manabu T. Nakamura,et al.  Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits , 2010, Experimental biology and medicine.

[233]  G. Golomb,et al.  Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[234]  J. Morelli,et al.  Vitiligo Treatment in Childhood: A State of the Art Review , 2010, Pediatric dermatology.

[235]  M. Martínez-Lorenzo,et al.  Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[236]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[237]  A. Samad,et al.  Development and Evaluation of Inhalational Liposomal System of Budesonide for Better Management of Asthma , 2010, Indian journal of pharmaceutical sciences.

[238]  R. Banerjee,et al.  In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[239]  P. Heydarpour,et al.  Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice , 2010, Epilepsy & Behavior.

[240]  Yuquan Wei,et al.  Gene therapy for psoriasis in the K14‐VEGF transgenic mouse model by topical transdermal delivery of interleukin‐4 using ultradeformable cationic liposome , 2010, The journal of gene medicine.

[241]  S. Jain,et al.  Drug-Cyclodextrin-Vesicles Dual Carrier Approach for Skin Targeting of Anti-acne Agent , 2010, AAPS PharmSciTech.

[242]  K. Csaky,et al.  Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[243]  U. Galili,et al.  Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction. , 2010, Burns : journal of the International Society for Burn Injuries.

[244]  A. Lamprecht,et al.  Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases , 2010, Journal of The Royal Society Interface.

[245]  K. Katsuoka,et al.  Selective induction of apoptosis in the hamster flank sebaceous gland organ by a topical liposome 5‐α‐reductase inhibitor: A treatment strategy for acne , 2010, The Journal of dermatology.

[246]  Donald Y M Leung,et al.  Allergic skin diseases. , 2010, The Journal of allergy and clinical immunology.

[247]  Jonathan A. Kopechek,et al.  Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1. , 2010, Molecular pharmaceutics.

[248]  S. Petersen,et al.  Local Transient Myocardial Liposomal Gene Transfer of Inducible Nitric Oxide Synthase Does Not Aggravate Myocardial Function and Fibrosis and Leads to Moderate Neovascularization in Chronic Myocardial Ischemia in Pigs , 2010, Microcirculation.

[249]  H F Edelhauser,et al.  Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV , 2009, Gene Therapy.

[250]  Aldo Jesorka,et al.  Liposomes: technologies and analytical applications. , 2008, Annual review of analytical chemistry.

[251]  B. Pulliam,et al.  Nanoparticles for drug delivery to the lungs. , 2007, Trends in biotechnology.

[252]  M. K. Bayliss,et al.  A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes , 2007, Drug Metabolism and Disposition.

[253]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[254]  C. Hartrick,et al.  Extended‐Release Epidural Morphine (DepoDur™): An Old Drug with a New Profile , 2005, Pain practice : the official journal of World Institute of Pain.

[255]  A. R. Domínguez,et al.  Liposomal cytarabine (DepoCyte®) for the treatment of neoplastic meningitis , 2005 .

[256]  G. Krueger,et al.  Psoriasis--recent advances in understanding its pathogenesis and treatment. , 2005, Journal of the American Academy of Dermatology.

[257]  A. Anagnostopoulos,et al.  The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia , 2005, Leukemia & lymphoma.

[258]  K. Blennow,et al.  Altered thalamic membrane phospholipids in schizophrenia: a postmortem study , 2004, Biological Psychiatry.

[259]  A. Santoro,et al.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[260]  N. Bressler,et al.  Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. , 2000, Investigative ophthalmology & visual science.

[261]  H. Schulz,et al.  Particle Deposition in the Respiratory Tract , 2000 .

[262]  M. Decramer,et al.  Regulation of mucociliary clearance in health and disease. , 1999, The European respiratory journal.

[263]  J. Patton,et al.  Mechanisms of macromolecule absorption by the lungs , 1996 .

[264]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[265]  Paulami Pal,et al.  Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery , 2019, European journal of ophthalmology.

[266]  Warren H. Finlay,et al.  Particle deposition in the respiratory tract , 2019, The Mechanics of Inhaled Pharmaceutical Aerosols.

[267]  S. Sadeghian,et al.  Physicochemical characteristics of liposomes are decisive for their antirestenosis efficacy following local delivery. , 2017, Nanomedicine.

[268]  Wen Tan,et al.  Preparation of a Sustained-Release Nebulized Aerosol of R-terbutaline Hydrochloride Liposome and Evaluation of Its Anti-asthmatic Effects via Pulmonary Delivery in Guinea Pigs , 2017, AAPS PharmSciTech.

[269]  V. Yellepeddi,et al.  Recent Advances in Topical Ocular Drug Delivery. , 2016, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[270]  Wei He,et al.  Biotinylated liposomes as potential carriers for the oral delivery of insulin. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[271]  Carlos Roberto Antonio,et al.  Nanotechnology in Dermatology* , 2014, Anais brasileiros de dermatologia.

[272]  J. Rosano,et al.  Targeted delivery of VEGF to treat myocardial infarction. , 2013, Advances in experimental medicine and biology.

[273]  Sameer Jadhav,et al.  Chemistry and Physics of Lipids , 2013 .

[274]  S. Kshirsagar,et al.  Design and development of liposomes for colon targeted drug delivery , 2012 .

[275]  R. Hamill,et al.  Parkinson's disease. , 2012, Sub-cellular biochemistry.

[276]  B. Rane,et al.  TRANSFERSOMES: A SURROGATED CARRIER FOR TRANSDERMAL DRUG DELIVERY SYSTEM , 2011 .

[277]  J. Adler-Moore,et al.  AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience. , 2002, The Journal of antimicrobial chemotherapy.

[278]  G. Oberdörster,et al.  Pulmonary deposition, clearance and effects of inhaled soluble and insoluble cadmium compounds. , 1992, IARC scientific publications.

[279]  N. Di Lascio,et al.  Tissue distribution of drug-metabolizing enzymes in humans. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.